Full-Time

Development and Operations Coordinator

Posted on 10/10/2025

Deadline 9/17/26
American Heart Association

American Heart Association

5,001-10,000 employees

No salary listed

Tucson, AZ, USA

Hybrid

On-site in Tucson; local travel for event planning.

Category
Operations & Logistics (2)
,
Requirements
  • High School Diploma or equivalent
  • Three (3) years prior relevant work experience that includes: Project management with ability to manage multiple projects simultaneously and meet specified timelines
  • Administrative expertise with complex clerical responsibilities and data management
  • Effective oral and written communication skills
  • Effective interpersonal skills with demonstrated ability to develop collaborative working relationships internally and externally
  • Ability to organize, plan and execute corporate events, both in-person and digital experiences
  • Proficiency in Microsoft Office applications
  • Ability to travel locally for event preparations and day of event coordination; requires access to reliable transportation at all times on an immediate basis
Responsibilities
  • Provides a wide variety of skilled event planning and data management support to the Southern Arizona Division, ensuring all programs, events and office functions run efficiently. Ensures a high quality of service is provided to all staff, volunteers, and other external and internal customers
  • Plans, manages and implements assigned events, including the Southern Arizona Heart Walk, Southern Arizona Go Red for Women luncheon, STEM Goes Red event and smaller, ancillary events throughout the year. Includes all aspects of event planning: event design, vendor selection and management, contract negotiation, visual innovation, budget management, resource optimization and execution excellence. Leads event day execution for assigned events
  • Partners with Event Planning Director to plan the Southern Arizona Heart Ball
  • In coordination with internal partners, recruits, orients, and trains event volunteers as needed. Manages volunteers on event day
  • Manages customer and campaign information utilizing American Heart Association systems accurately, timely and completely in accordance with established guidelines. Understands and interprets data to ensure that it is complete and accurate, identifying and addressing any gaps in a timely and self-directed manner
  • Processes invoices for payment, conducts research as assigned, organizes and orders event supplies, maintains inventory tracker. May assist with event set-up and tear-down
  • Ensures the collateral, signage and visual needs of events are produced and adhere to American Heart Association branding guidelines
  • Procures necessary resources and may solicit in-kind donations
  • Coordinates business operations for the Tucson office including facilitating operations orientations, coordinating office safety inspections and emergency response planning/training, and ensuring office needs are managed consistent with policies and standards for safe, effective, and efficient operations
  • Provides scheduling and expense report support to the Executive Director
  • Responsible for accurate, timely processing of donations in accordance with established requirements and standards
  • Proactively ensures timely communication with internal and external partners and customers, supporting collaboration to achieve shared goals
Desired Qualifications
  • Demonstrated ability to recruit, train and manage volunteers with success in delegating and accomplishing goals through empowering volunteers
  • Knowledge of corporate and community networks
  • Knowledge of American Heart Association’s mission and programs
American Heart Association

American Heart Association

View

Company Size

5,001-10,000

Company Stage

Grant

Total Funding

$700K

Headquarters

Dallas, Texas

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Heart Walk, Kids Heart Challenge rank top 5 U.S. fundraisers nationally.
  • Global expansion via CPR guidelines forums across MENA, India, Japan.
  • Corporate partnerships with Alnylam, Charles River accelerate research and awareness.

What critics are saying

  • Corporate sponsor dependence undermines independence; Alnylam partnership promotes proprietary drugs.
  • New dietary guidelines face backlash, eroding credibility with health professionals.
  • $20M Fontan program risks failure to deliver monitoring tools, damaging reputation.

What makes American Heart Association unique

  • Largest nonprofit cardiovascular research funder with 100+ year track record.
  • 35 million global volunteers amplify reach beyond traditional nonprofit scale.
  • Convenes multidisciplinary health systems for care coordination and quality improvement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

Employee Assistance Program

Wellness Program

Telemedicine

Tuition Reimbursement

Paid Vacation

Paid Holidays

Hybrid Work Options

Remote Work Options

Company News

Contract Pharma
Apr 10th, 2026
Charles River, American Heart Association partner to advance cardiovascular health awareness.

Charles River, American Heart Association partner to advance cardiovascular health awareness. Charles River to support the American Heart Association's Heart of Boston campaign, helping drive efforts to improve health outcomes across Greater Boston and the country. April 10, 2026 Associate Editor Charles River Laboratories International Inc. has partnered with the American Heart Association to support cardiovascular disease awareness, prevention, and community health initiatives. Through this collaboration, Charles River will support the American Heart Association's Heart of Boston campaign, helping drive efforts to improve health outcomes across Greater Boston and the country. "New data from the American Heart Association shows that cardiovascular disease continues to take an enormous toll on families and communities," said Kristen Eisenhauer, Chief Commercial Officer, Charles River. "We are proud to support the prevention, education, and science-driven efforts needed to help sustain progress and improve cardiovascular health worldwide." The joint effort comes at a critical time for public health. According to the American Heart Association's recently released 2026 Heart Disease and Stroke Statistics Update, heart disease remains the leading cause of death in the United States, while stroke is now the fourth-leading cause of death. Together, heart disease and stroke account for more than one in four U.S. deaths, despite recent improvements in overall cardiovascular mortality. While the latest data shows a decline in total cardiovascular deaths following years of increases associated with the COVID-19 pandemic, the American Heart Association's update underscores persistent risk factors across the population, including high rates of high blood pressure, diabetes, and obesity. These findings highlight the continued need for education, research, and public-private partnerships to advance long-term cardiovascular health. More Charles River news. Therna Biosciences, a biotechnology company pioneering programmable RNA therapeutics, recently joined forces with Charles River to advance single-patient RNA medicines for individuals with severe, ultra-rare disorders.

HealthTech HotSpot
Apr 9th, 2026
Charles River advances cardiovascular health awareness Through support of the American Heart Association.

Charles River advances cardiovascular health awareness Through support of the American Heart Association. WILMINGTON, Mass.-(BUSINESS WIRE)-$CRL #CDMO-Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world's leading nonprofit organization focused on heart and brain health, to support cardiovascular disease awareness, prevention, and community health initiatives. "New data from the American Heart Association shows that cardiovascular disease continues to take an enormous toll on families and communities," said Kristen Eisenhauer, Chief Commercial Officer, Charles River. "We are proud to support the prevention, education, and science-driven efforts needed to help sustain progress and improve cardiovascular health worldwide." Through this collaboration, Charles River will support the American Heart Association's Heart of Boston campaign, helping drive efforts to improve health outcomes across Greater Boston and the country. The support reinforces shared commitments to science-driven progress, prevention, and community engagement, and aligns with Charles River's corporate purpose - Together, HealthTech HotSpot LLC Create Healthier Lives - and its Corporate Citizenship strategy focused on advancing human health beyond the laboratory. The joint effort comes at a critical time for public health. According to the American Heart Association's recently released 2026 Heart Disease and Stroke Statistics Update, heart disease remains the leading cause of death in the United States, while stroke is now the fourth-leading cause of death. Together, heart disease and stroke account for more than one in four U.S. deaths, despite recent improvements in overall cardiovascular mortality. While the latest data shows a decline in total cardiovascular deaths following years of increases associated with the COVID-19 pandemic, the American Heart Association's update underscores persistent risk factors across the population, including high rates of high blood pressure, diabetes, and obesity. These findings highlight the continued need for education, research, and public-private partnerships to advance long-term cardiovascular health. About Charles River Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development, and safe manufacture of new therapies for the patients who need them. To learn more, visit www.criver.com. Charles River Investor Contact: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 [email protected] Charles River Media Contact: Amy Cianciaruso Corporate Senior Vice President, Chief Communications Officer 781.222.6168 [email protected] April 10th, 2026 April 9th, 2026

Business Insider
Apr 7th, 2026
SimpliFed raises $10.8M Series A to expand virtual maternal health platform from lactation to full OB care

SimpliFed, a virtual maternal healthcare platform, has raised $10.8 million in an oversubscribed Series A round led by Morningside and Hesperia Capital. Foreground Capital and existing investors including AHA Social Impact Fund and Elizabeth Street Ventures participated. The company, which provides virtual breastfeeding and baby feeding support, is expanding into virtual OB services to offer prenatal and postpartum care for low-risk patients. SimpliFed connects families with certified lactation consultants and maternal health providers through telehealth visits, integrating with major electronic medical record systems. SimpliFed is on track to serve 5% of all US births in 2026 and is in network with major commercial health plans and Medicaid across several states. The funding will support growth of its Maternal Health Operating System and partnerships with health systems and OBGYN clinics.

American Heart Association
Mar 30th, 2026
New $20M effort aims to address critical gaps in care for people with single ventricle heart disease.

New $20M effort aims to address critical gaps in care for people with single ventricle heart disease. The American Heart Association and Additional Ventures develop program focused on improving long-term health for people living with Fontan circulation DALLAS, March 30, 2026 - The lifesaving surgery used to treat children with single ventricle heart disease, the Fontan procedure, can pose serious health complications throughout life. The American Heart Association, devoted to changing the future to a world of healthier lives for all and Additional Ventures, a research foundation working toward a cure for single ventricle heart disease, have committed a combined $20M to advance a coordinated, collaborative approach to improving the ability to predict, prevent and treat health complications in people living with Fontan circulation. Single ventricle heart disease affects about 6 in 10,0000 babies born in the US each year[1]. These children are born with only one working heart pump and must rely on a surgically created circulation (the Fontan circulation) to reroute blood through the body. While lifesaving, this circulation places long-term strain on the body and can lead to progressive damage across multiple organs. Today, clinicians lack reliable ways to monitor Fontan health, making them unable to detect early signs of decline. As a result, many patients appear stable until they suddenly experience severe complications that can be fatal or severely impact quality of life. The program will bring together clinicians, researchers and patients to generate scientific and clinical insights and develop tools to better guide care for people living with Fontan circulation. The program combines the strength of the American Heart Association's research infrastructure, guideline development, data coordination and registry science with Additional Ventures' leadership in single ventricle strategy, deep scientific expertise and unparalleled network across the single ventricle heart disease ecosystem. "People with Fontan circulation often develop complications with other organs in the body including the liver, kidneys and lungs," said Mariell Jessup, M.D., FAHA, chief medical and science officer of the American Heart Association. "The coordination between our two organizations will generate data and insight that can help patients and clinicians better monitor their health and intervene earlier." "While lifesaving, Fontan circulation creates complex, lifelong health challenges for single ventricle heart disease patients that we still do not fully understand," said Kirstie Keller, PhD, chief executive officer of Additional Ventures. "Through this collaboration, we will work with researchers, clinicians and patients to generate the scientific insights and tools needed to predict, detect and manage complications earlier. By building these resources, we hope to enable a more proactive, science-informed approach to lifelong care for Fontan patients. The six-year, multi-phase strategy begins with evaluating current approaches to monitoring Fontan circulation patients; identifying gaps in care, data and infrastructure; and engaging patients, clinicians and scientists in program design and implementation. Ultimately, the goal is to establish the scientific foundation and clinical tools needed to move the field from reactive care to proactive health monitoring of patients with Fontan circulation, creating the infrastructure for a future standard of care. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. About Additional Ventures Additional Ventures is a research foundation committed to curing single ventricle heart disease through transformative research and strategic investments that revolutionize treatment and care. By combining deep scientific expertise with strategic, flexible funding, Additional Ventures supports bold, collaborative research across the translational pipeline. Since its founding in 2020, Additional Ventures has committed more than $110 million to single ventricle heart disease research. Learn more about our work and progress in our most recent Impact Report, at additionalventures.org, or by following us on LinkedIn. For Media Inquiries: 214-706-1173 For Public Inquiries: 1-800-AHA-USA1 (242-8721)

CBS News
Mar 29th, 2026
New heart health dietary guidelines.

New heart health dietary guidelines. The American Heart Association has released new dietary guidelines on how to stay heart healthy to improve quality of life and save lives. Dr. Celine Gounder breaks down what to know. 4h ago Around the web. 60 minutes.

INACTIVE